|
2025
|
G/S
|
Pharmaceutical preparations for cancer; pharmaceutical preparations for rheumatoid arthritis; pha... |
|
2024
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for the treatment of osteoporosis; pharm... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical products for the
treatment of bone diseases; pharmac... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical products for the treatment of bone diseases; pharmace... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceutical preparations for
the treatment of osteoporosis; phar... |
|
|
Invention
|
Expression cassette for production of high-expression and high-functionality target protein and u... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations of therapeut... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune diseases |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune
diseases. |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune diseases. |
|
|
Invention
|
Method for treating tnfα-related diseases. The present invention relates to a method for treating... |
|
|
G/S
|
Pharmaceutical preparations for respiratory organs; allergy
medications; immunizing agent; immun... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto immune diseases and autoimmune disorders; p... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of autoimmune diseases and autoimmune disorders |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune
diseases; pharmaceutical preparatio... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of auto-immune diseases; pharmaceutical preparation... |
|
|
Invention
|
Stable liquid formula.
Disclosed is a stable liquid formulation, comprising an antibody or antig... |
|
|
Invention
|
Pharmaceutical composition containing azilsartan for treating hypertension. The present invention... |
|
|
Invention
|
Stable pharmaceutical formulation and process for manufacturing drug product. A stable pharmaceut... |
|
|
Invention
|
Method and device for environmental and utility monitoring of pharmaceutical production facility.... |
|
|
Invention
|
Stable liquid pharmaceutical preparation.
The present invention provides a stable liquid pharmac... |
|
2023
|
G/S
|
Ophthalmic preparations; pharmaceutical preparations for the treatment of angiogenesis. |
|
|
G/S
|
Pharmaceutical preparations for respiratory organs; allergy medications; immunizing agent; immuno... |
|
|
G/S
|
Ophthalmic preparations; pharmaceutical preparations for the treatment of angiogenesis |
|
|
G/S
|
Pharmaceutical preparations for treating respiratory organs; allergy medications; immunizing agen... |
|
|
G/S
|
Ophthalmic preparations; pharmaceutical preparations for the
treatment of angiogenesis. |
|
|
Invention
|
Dual-strength odor-shielding pharmaceutical composition. The present invention relates to a table... |
|
|
G/S
|
Reagent paper for inspection other than for medical or veterinary purposes; china clay; by-produc... |
|
|
G/S
|
Reagent paper for inspection (other than for medical or
veterinary purposes); china clay; by-pro... |
|
|
G/S
|
Pharmaceutical preparations; antibody treatment
preparations; pharmaceuticals; drugs for medical... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of cancer, of oncological diseases and disorders, a... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceuticals; drugs for medical purposes; preparations for the tr... |
|
|
G/S
|
Pharmaceutical products for the treatment of bone diseases; pharmaceutical preparations for the t... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of bone diseases and disorders, oncological and met... |
|
|
G/S
|
Pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for t... |
|
|
G/S
|
Pharmaceutical preparations; pharmaceuticals; drugs for
medical purposes; preparations for the t... |
|
2022
|
Invention
|
Method for expressing target protein. The present invention relates to a method for expressing a ... |
|
|
Invention
|
Stability-improved pharmaceutical composition for treatment of diabetes mellitus. The present inv... |
|
|
Invention
|
Composition comprising at least two sars-coronavirus-2-neutralizing binding molecules. The presen... |
|
|
Invention
|
Sars-coronavirus-2-neutralizing binding molecule that binds to epitope of sars-coronavirus-2 spik... |
|
|
Invention
|
Sars-coronavirus-2 fusion protein and immunogenic composition comprising same. The present invent... |
|
|
Invention
|
Immunogenic composition comprising multivalent streptococcus pneumoniae polysaccharide-protein co... |
|
2021
|
Invention
|
Clinical supplies management method and device using same. The present invention relates to a cli... |
|
|
Invention
|
Sars-coronavirus infection diagnosis binding molecule that binds to spike protein on surface of s... |
|
|
Invention
|
Stable pharmaceutical formulation, vial, cartridge, pre-filled syringe and auto-injector comprisi... |
|
|
Invention
|
Stable pharmaceutical formulation. A stable pharmaceutical preparation according to the present i... |
|
|
Invention
|
Stable pharmaceutical preparation. A stable pharmaceutical preparation according to the present i... |
|
|
Invention
|
Stable pharmaceutical formulation. The present invention relates to a stable pharmaceutical formu... |
|
|
Invention
|
Immunogenic composition comprising pneumococcal polysaccharide-cell wall-derived material conjuga... |
|
|
Invention
|
Stable pharmaceutical preparation.
A stable pharmaceutical formulation according to the present ... |
|
|
Invention
|
Binding molecule having neutralizing activity against coronavirus superfamily. The present invent... |
|
|
Invention
|
Dosage regimen for preventing or treating sars-coronavirus infection. The present application rel... |
|
|
Invention
|
Pharmaceutical composition for treatment of hypertrophic cardiomyopathy and treatment method usin... |
|
|
Invention
|
Polymorphic form of (-)-cibenzoline succinate.
The present invention relates to a crystalline fo... |
|
|
Invention
|
Polymorphic form of (-)-cibenzoline succinate. The present invention relates to a crystal form of... |
|
|
Invention
|
Binding molecule having neutralizing activity against sars-coronavirus-2.
The present invention ... |
|
|
Invention
|
Binding molecule having neutralizing activity against sars-coronavirus-2. The present invention r... |
|
|
Invention
|
Stable liquid formula comprising anti-tnfa antibody, acetate buffer, and glycine. Disclosed is a ... |
|
|
Invention
|
Varicella zoster virus fusion protein and immunogenic composition comprising same.
The present i... |
|
|
Invention
|
Varicella zoster virus fusion protein and immunogenic composition comprising same. The present in... |
|
2020
|
Invention
|
Expression cassette including intron for high expression of protein of interest and use thereof. ... |
|
|
Invention
|
Pharmaceutical formulation comprising cibenzoline or salt thereof.
A pharmaceutical formulation ... |
|
|
Invention
|
Methods for treating tnfa-related diseases.
The present prevention relates to methods for treati... |
|
2019
|
Invention
|
Dosing regimen for treating influenza virus diseases. The present invention pertains to a dosing ... |
|
|
Invention
|
Pharmaceutical composition for use in treatment of hypertrophic cardiomyopathy.
The present inve... |
|
|
Invention
|
Novel method for preparing (-)-cibenzoline succinate.
The present invention relates to a crystal... |
|
|
Invention
|
Stable liquid pharmaceutical preparation. A stable liquid pharmaceutical formulation according to... |
|
2018
|
Invention
|
Binding molecule having neutralizing activity against middle east respiratory syndrome-coronaviru... |
|
|
Invention
|
Methods for treating tnfa-related diseases.
The present invention relates to a method of TNF-α-r... |
|
2017
|
Invention
|
Stable liquid pharmaceutical formulation of anti-influenza virus antibody. A stable liquid pharma... |
